250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Life Science Angel Investors in United States in April 2025

A list of 50 angel investors that invest in Life science startups based in United states. We rank investors based on the number of investments they made in Life science companies from United states. We update this investor list every month.

Top 50 Life Science Angel Investors in United States in April 2025

Investor Life Science United States investments
Sahin Boydas 5
bumpkins profile 4
Milad Alucozai 4
Chris Gibson 3
Kevin Moore 3
Esther Dyson 3
Darian Shirazi 3
Erik Peterson 3
Nitesh Banta 2
Nat Turner 2
Joshua Elkington 2
Elad Gil 2
Patrick Collison 2
Jonathan Milner 2
Jay Zaveri 2
Kathryn Haun 2
David R. Walt 2
Peter Harris 2
CJ Reim 2
Craig Mundie 2
Mei Z. 2
Brian S. Cohen 2
Michael Chambers 2
Lars Fjeldsoe-Nielsen 2
Zach Weinberg 2
Balaji Srinivasan 2
Kevin Mahaffey 2
Joe Betts-Lacroix 2
Ankit Jain 2
James Hong 2
Sujay Jaswa 2
Patrick Yang 2
Angela Jackson 1
Alice Zhang 1
Daniel M. Bradbury 1
Willard Umphrey 1
Paul Manning 1
Lu Yoh-Chie 1
Scott Garber 1
Wes Osbourn 1
Ali Shaaban 1
Jeff Raikes 1
Idris Ayodeji Bello 1
Haig Farris 1
Douglas Hansen 1
Norman Sorensen 1
Leonardo DiCaprio 1
Ling Wong 1
Chloe Sladden 1
Jude Gomila 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Sahin Boydas Angel · San Francisco Bay Area, California, United States · 18 investments in the past 12 months
Sahin Boydas is the founder of Stealth AI Startup. He previously served as the Head of Turkiye, Distributed Teams, Bootcamp, and App Ecosystem at Gusto. He attended Koç University.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Seed, Series A, Series B
  • United States, Mexico, Spain
Portfolio highlights
  • CapStack Technologies — Discover Capstack, the leading bank-to-bank marketplace driving banking digital transformation. Join the innovation wave and transform your banking experience now!
  • Sully.ai — Sully is deploying autonomous medical workers into healthcare organizations to address the most expensive line item in healthcare: payroll ($800b/yr in the US alone). Today, Sully's autonomous workers can perform most medical staff tasks 100x faster and 20x cheaper. From Digital Triage Nurses and Autonomous Medical Assistants to DigitalScribes and Digital Receptionists, our workers can automate patient check-in, assessments, documentation, diagnosis support, and billing that integrates with Electronic Health Records (EHRs)
  • Biostate AI — Biostate AI develops generative AI that benefit all human health.
bumpkins profile Angel
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Pre-Seed
  • United States, Canada, India
Portfolio highlights
  • Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
  • Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
  • Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Milad Alucozai Angel · San Francisco, California, United States
Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Pre-Seed
  • United States, Canada, United Kingdom
Portfolio highlights
  • Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Chris Gibson Angel · Salt Lake City, Utah, United States
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more
Investment focus
  • Biotechnology, Health Care, Life Science
  • Series A, Seed
  • United States, France, Switzerland
Portfolio highlights
  • Amenities Health — Boost revenue and foster patient loyalty with our turnkey membership platform, offering an exceptional digital experience that keeps patients engaged and drives growth.
  • Cradle — Design better proteins
  • Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Kevin Moore Angel · Dallas, Texas, United States
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Pre-Seed, Angel
  • United States, India, Canada
Portfolio highlights
  • Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
  • SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
  • Augmend — Create documentation and an AI assistant from any video.
Esther Dyson Angel · New York, New York, United States
Esther Dyson - Founder @ Way to Wellville
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Funding Round
  • United States, Canada, Russian Federation
Portfolio highlights
  • Ezra AI — Ezra provides full-body MRI screening for potential early cancer and abnormalities in up to 13 organs. Book a scan today.
  • Way — Way combines intuitive eating with behavior science for mindful habits. 73.5% of app users report transformed thinking post-program.
  • Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Darian Shirazi Angel · San Francisco, California, United States · 14 investments in the past 12 months
Darian Shirazi is the Managaing Partner of Gradient.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Seed, Series A, Series B
  • United States, Germany, Canada
Portfolio highlights
  • Valdera — Valdera is the sourcing and procurement platform that makes it easy to buy or sell chemicals, ingredients, and raw materials. We partner with segment leaders, ranging from the world's largest CPG manufacturers to household names in the beauty industry.
  • Legora — By streamlining and simplifying legal workflows, we empower elite law firms and legal professionals to work more efficiently and effectively. Enabling them to focus on higher-value tasks and deliver exceptional results for their clients.
  • rift — The sales platform built to help your focus.
Erik Peterson Angel · Chicago, Illinois, United States
Erik Peterson is the Founder at DormTrader.
Show more
Investment focus
  • Software, Biotechnology, SaaS
  • Seed, Equity Crowdfunding, Series A
  • United States, Canada, Algeria
Portfolio highlights
  • Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
  • Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
  • Altay Therapeutics — Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It wasfounded in 2019 and is headquartered in San Francisco, California.
Nitesh Banta Angel · New York, New York, United States · 4 investments in the past 12 months
Nitesh Banta is the Co-Founder & CEO at B12.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Pre-Seed
  • United States, Canada, India
Portfolio highlights
  • Protege — Protege is the platform for AI Training Data. Protege works with data holders and model builders to empower them to share training data for AI model development.
  • Chai Discovery — Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
  • Draftboard — Refer your friends, community and following with our hiring platform, and get paid when they get hired! Start referring (or hiring!) now!
Nat Turner Angel · New York, New York, United States
Before co-founding Flatiron, Nat was Co-Founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Nat started numerousinternet companies and also worked at Say Media and First Round Capital. An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Nat earned a Bachelor of Science degree cum laude in Economics with concentrations in Entrepreneurship and Marketing from The Wharton School of the University of Pennsylvania. In his spare time, Nat is an avid golfer and tries to trick trout with fake bugs.
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Series B
  • United States, China, Colombia
Portfolio highlights
  • CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
  • Collectors — Helping collectors to pursue their passion.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Joshua Elkington Angel
Joshua Elkington
Show more
Investment focus
  • Biopharma, Life Science, Biotechnology
  • Seed
  • United States
Portfolio highlights
  • Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
  • Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Elad Gil Angel · San Francisco, California, United States · 23 investments in the past 12 months
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Series B
  • United States, United Kingdom, Israel
Portfolio highlights
  • Quanta — Quanta provides software companies with real-time financial clarity and empowerment. Quanta envision a world in which all business accounting tasks that are not creative in nature are automated, leaving finance teams and business owners to focus solely on strategic and creative work.
  • Yutori — Yutori is part of a slew of AI startups creating autonomous agents, or systems that use AI to perform actions on their own.
  • Cognition — Cognition is an applied artificial intelligence lab that focuses on reasoning and code.
Patrick Collison Angel · San Francisco, California, United States · 4 investments in the past 12 months
Patrick Collison is the Co-Founder, CEO and Content Strategist of Stripe. He previously worked at Auctomatic as a Co-Founder. Patrick Collison attended Massachusetts Institute of Technology.
Show more
Investment focus
  • Software, Information Technology, Financial Services
  • Series A, Seed, Series C
  • United States, United Kingdom, India
Portfolio highlights
  • Cortex — Cortex makes it easy for engineering organizations to gain visibility into their services and deliver high quality software.
  • Cursor — Cursor is an AI code editor used to enhance software engineering productivity. It offers a platform allowing developers to write code using predictive typing and natural language instructions. It also integrates with their existing codebase, ensuring privacy and security with SOC 2 certification.
  • Pacific Fusion — Pacific Fusion was founded in 2023 with the mission to power the world with abundant, affordable, clean energy.
Jonathan Milner Angel · Cambridge, Massachusetts, United States · 10 investments in the past 12 months
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Series B
  • United Kingdom, United States, Spain
Portfolio highlights
  • Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
  • Epitopea — Epitopea is a transatlantic biotechnology company developing transformational immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. Cryptigen™ TSAs are discovered by a proprietary approach deploying immunopetidomics, mass spectrometry, genomics, andbioinformatics, which allows the identification of conserved, aberrantly-expressed, tumour-specific antigens, hidden in cancer's 'junk' DNA. These hidden Cryptigen™ TSAs have been identified by research led by Drs. Claude Perreault and Pierre Thibault at the Institute for Research in Immunology and Cancer at Université de Montréal.
  • Exciting Instruments — Exciting Instruments Limited is a joint company founded in Sheffield that combines the software prowess of Bulldozer Limited with Dr. Timothy Craggs' knowledge of single molecules. Through the use of cloud connectivity and real-time data visualisation, we are a genuine science and software partnership on a mission to assist you in streamliningthe procedure for creating discoveries in biophysics, life sciences, drug discovery, and medical diagnostics.
Jay Zaveri Angel · San Francisco Bay Area, California, United States
Jay Zaveri has been serving Natural Capital as a partner since Jan 2019. He also ran venture and incubations for Social Capital, was founder of CloudOn and Future Thought Productions.
Show more
Investment focus
  • Health Care, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • United States, Japan, Canada
Portfolio highlights
  • Cleerly — Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
  • BitClout — BitClout is a platform owned by its users. Bitcoin is decentralizing money, BitClout is decentralizing social media.
  • Kingdom Supercultures — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.
Kathryn Haun Angel · San Francisco, California, United States
Katie Haun is a General Partner at Andreessen Horowitz. She serves on the boards of Coinbase and HackerOne and has invested in and advised tech companies from seed to Series E stage. Katie teaches a management course at Stanford Business School and previously taught cybercrime at Stanford Law School. Previously, she spent a decade as a federalprosecutor with the U.S. Department of Justice focusing on fraud, cyber, and corporate crime alongside agencies including the SEC, FBI, and Treasury. She created the government’s first cryptocurrency task force and led investigations into the Mt. Gox hack and the corrupt agents on the Silk Road task force. She also prosecuted RICO murders, organized crime, public corruption, gangs, and money laundering, and held senior policy positions at headquarters in both the National Security Division and Attorney General’s office where her portfolio included antitrust, tax, and national security. Katie clerked for U.S. Supreme Court Justice Anthony Kennedy and is an honors graduate of Stanford Law School.
Show more
Investment focus
  • Blockchain, Financial Services, FinTech
  • Funding Round, Seed, Series A
  • United States, United Kingdom
Portfolio highlights
  • dub — The first Copy-Trading platform for stocks. Copy anyone's investments. For free. Regulated Broker-Dealer member FINRA and SIPC & FDIC insured.
  • Aptos — Building products, applications, and tooling on the Aptos blockchain. Bringing the benefits of decentralization to the masses.
  • Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.
David R. Walt Angel · Boston, Massachusetts, United States
David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.
Show more
Investment focus
  • Biotechnology, Genetics, Life Science
  • Seed, Series A, Series B
  • United States
Portfolio highlights
  • Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
  • Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
  • Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Peter Harris Angel
Peter Harris
Show more
Investment focus
  • Life Science, Biotechnology, Health Diagnostics
  • Seed
  • United States
Portfolio highlights
  • CND Life Sciences — Our suite of neurodiagnostic tests give clinicians access to objective pathological insights on diseases that are often difficult to diagnose
CJ Reim Angel · San Francisco, California, United States
CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.
Show more
Investment focus
  • E-Commerce, Robotics, Software
  • Series A, Seed, Pre-Seed
  • United States
Portfolio highlights
  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
  • Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Craig Mundie Angel
Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter.
Show more
Investment focus
  • Life Science, Chemical, Genetics
  • Seed, Series B, Series C
  • United States
Portfolio highlights
  • Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
  • Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Mei Z. Angel · San Francisco Bay Area, California, United States · 9 investments in the past 12 months
Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab
Show more
Investment focus
  • Software, Artificial Intelligence, Biotechnology
  • Seed, Pre-Seed, Series A
  • United States, United Kingdom, Singapore
Portfolio highlights
  • FlyMy.AI — Real-time AI cloud
  • WilsonAI — WilsonAI makes the world's best AI paralegal for company's legal teams. It acts as an intelligent legal front door and assists with automating workflows while maintaining oversight.
  • BenchFlow — Largest benchmark hub
Brian S. Cohen Angel · New York, New York, United States
Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBMCorporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses.Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community.Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally.Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model.Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications.
Show more
Investment focus
  • Software, SaaS, Mobile
  • Seed, Series A, Funding Round
  • United States, Israel
Portfolio highlights
  • Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
  • CourseHorse — CourseHorse is a provider of a learning platform used to centralize the learning opportunities. Its platform partners with providers of Spanish lessons, cooking courses, yoga classes, and other classes to create a single destination for people seeking personal interest education that enables people to increase ease and confidence in discovering thepath to personal enrichment.It was founded in 2011 and is headquartered in New York.
  • Boundless Mind — Thrive Global's mission is to end the burnout epidemic with sustainable, science-based solutions that unlock employee performance and enhance well-being through our behavior change technology.
Michael Chambers Angel · Fargo, North Dakota, United States
Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.
Show more
Investment focus
  • Biotechnology, Genetics, Life Science
  • Series A, Funding Round
  • United States
Portfolio highlights
  • Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
  • Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
  • 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
Lars Fjeldsoe-Nielsen Angel · London, England, United Kingdom
Lars Fjeldsoe-Nielsen is a Co-Founder & serves as a Partner at 2xN. Lars Fjeldsoe-Nielsen was General Partner at Balderton Capital in London from 2015-2021 through four funds. He joined after spending a decade in Silicon Valley where he was with Uber and Dropbox.Since 2012 his venture track record includes two IPOs (Uber, Dropbox) and 11acquisitions.Lars joined Balderton from Uber which he joined when the company was operating in less than 20 cities. His role as Vice-President resulted in strategic alliances. Lars joined Uber from Dropbox as one of the company’s first 25 employees. As Head of Mobile, his growth deals with Samsung and other mobile OEMs helped Dropbox reach its first 100 million users. Prior to that Lars held positions at Voicesignal (acq. Nuance), Skyhook Wireless (acq. TruePosition), Ness Technologies (acq. Opentable), 3Jam (acq. Skype) and T9 Tegic (acq. AOL). More than a billion people have used the software and services distributed as a result of mobile growth partnerships led by Lars.His venture investments include Voi (Raine), Labster (A16Z), Hiya (Ericsson), Cambridge Quantum Computing (HON), Hopin (A16Z), Opensea (A16Z), Yassir (YC), Beacon (Eric Schmidt), The org (Sequoia), Octant (A16Z), Zycada (Khosla), Monarch Money (Accel) and Kukua (Tencent), Dubsmash (acq. Reddit), Tempow (acq. Google), Rahko (acq. Odyssey Therapeutics), Pocket (acq. Mozilla), Blue Bottle (acq. Nestle), Marble (acq. Caterpillar).Lars, who is Danish-Portuguese, grew up across Africa and served with the Royal Danish Guards. He holds a MBA from London Business School, where he also serves on the Board of Trustees, an MSc from Oxford University Keble College and a BSc from King’s College, London. He lives in London with his wife and three children.
Show more
Investment focus
  • Software, Information Technology, Mobile Apps
  • Seed, Series A, Funding Round
  • United States, Denmark, United Kingdom
Portfolio highlights
  • HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products. 
e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
  • LiveFlow — The easiest way to bring financial data into your spreadsheet. Automate your finances, consolidate your accounts and collaborate in real-time. Try LiveFlow for free today!
  • Quantrol Ox — Building Machine Learning Based Software for Quantum Control with a goal to maximise quantum computer uptime.
Zach Weinberg Angel · New York, New York, United States
Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.
Show more
Investment focus
  • Health Care, Software, SaaS
  • Seed, Series A, Pre-Seed
  • United States, Israel, United Kingdom
Portfolio highlights
  • Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
  • Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
Balaji Srinivasan Angel · San Francisco Bay Area, California, United States · 18 investments in the past 12 months
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.
Show more
Investment focus
  • Blockchain, Cryptocurrency, Software
  • Seed, Pre-Seed, Series A
  • United States, India, Singapore
Portfolio highlights
  • The Arena — Arena. social is a cutting-edge SocialFi platform that is revolutionizing how content producers interact, network, and make money from their work.
  • Lica World — Hire Lica, AI Video Producer for Product, Sales, And Customer Success Teams
  • OpenGradient — OpenGradient is a leading decentralized AI platform for open-source model hosting, secure inference, agentic reasoning, and application deployment. By developing tooling and a feature-rich platform that makes developing AI workflows both secure and seamless, OpenGradient empowers developers with the ability to build in its ecosystem of intelligentand optimized AI-empowered applications. With native model hosting, permissionless composability, and secure inference execution, OpenGradient also aims to accelerate open-source AI by democratizing model ownership, improving verifiability guarantees, and promoting censorship-resistant model access.Our heterogeneous AI compute architecture (HACA) and our proprietary library NeuroML scale secure AI workflows with features like inference, agentic reasoning, statistical analysis, and more. OpenGradient also accelerates open-source innovation with a web portal and SDK for Web2 developers to leverage our AI stack without navigating blockchain complexities, while enjoying the security and composability benefits of decentralized infrastructure.
Kevin Mahaffey Angel · San Francisco, California, United States · 6 investments in the past 12 months
Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.
Show more
Investment focus
  • Software, SaaS, Enterprise Software
  • Seed, Series A, Pre-Seed
  • United States, Canada, Israel
Portfolio highlights
  • Karman+ — Mining near Earth asteroids
  • Knostic — Knostic provides need-to-know access controls for Large Language Models (LLMs). Its knowledge-centric capabilities enable enterprises to expedite the deployment of LLMs and drive AI-powered innovation while maintaining value, security, and safety.
  • Resquared — Resquared has everything you need and more to reach local businesses. Contact data on every local business, optimized email and social outreach tools, and step-by-step built-in playbooks.
Joe Betts-Lacroix Angel · San Francisco Bay Area, California, United States
Joe Betts-Lacroix is the CEO at Retro. He previously worked at OQO as a Co-Founder and CTO. Joe Betts-Lacroix attended Harvard University and Massachusetts Institute of Technology.
Show more
Investment focus
  • Health Care, Life Science, Biotechnology
  • Seed
  • United States
Portfolio highlights
  • VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
  • Spring Discovery — Giving Scientists AI Superpowers
Ankit Jain Angel · San Francisco, California, United States
Ankit Jain is the Founder and CEO of Infinitus Systems.
Show more
Investment focus
  • Health Care, Medical, Hospital
  • Seed, Pre-Seed
  • United States
Portfolio highlights
  • Advex AI — Advex AI assists the world's largest manufacturers in cutting costs and increasing productivity by producing highly dependable computer vision models in hours.
  • RapidClaims — Rapid Claims helps businesses autonomously code medical charts, find up-coding opportunities, improve the CDI process and reduce denials.
  • Empower Sleep — Empower Sleep provides personalized sleep care online
James Hong Angel · San Francisco, California, United States
James Hong
Show more
Investment focus
  • E-Commerce, Software, Internet
  • Seed, Series A, Angel
  • United States
Portfolio highlights
  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Deep Infra — Deep Infra offers cost-effective, scalable, easy-to-deploy, and production-ready machine-learning models and infrastructures for deep-learning models.
  • Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Sujay Jaswa Angel · San Francisco, California, United States
Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School.
Show more
Investment focus
  • Software, FinTech, Financial Services
  • Seed, Series B, Series A
  • United States, Spain, Germany
Portfolio highlights
  • HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products. 
e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
  • point.me — Search and book award flights and maximize the value of your points. Travel on points for less with point.me's flight award search tool.
  • Fireside — Fireside is the first interactive streaming platform that invites you to be part of the show. Co-founded by Falon Fatemi and Mark Cuban the media and entertainment networks of the future are emerging on Fireside.
Patrick Yang Angel · San Francisco, California, United States
Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games.
Show more
Investment focus
  • Software, Artificial Intelligence, Health Care
  • Series A, Seed, Series B
  • United States
Portfolio highlights
  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
  • Innerwell — Innerwell combines personalized guidance from licensed therapists like you with the expansive power of psychedelics to treat anxiety and depression.
Angela Jackson Angel · Portland, Oregon, United States
Angela Jackson is an active angel investor and coach to emerging companies and entrepreneurs. Her background is in marketing/sales, strategy, fundraising and leadership. In addition to her role as the Portland/Oregon Keiretsu Forum Chapter President, Angela is also Managing Director & Fund Manager at Bridge City Ventures Portland SeedFund, Manager of the Portland State University Business Accelerator, an investor in Oregon Angel Fund and co-chair of Angel Oregon’s Consumer/Active Lifestyle investment track and serves on the company selection committee for Women’s Investment Network. Angela also advises nonprofit/social entrepreneurs and recently was an “Ask the Expert” consultant to Craigslist Foundation social entrepreneurs in New York. She is an advisor/investor with Mercy Corps’ Phoenix Fund, which helps microenterprises in third world areas succeed. Growing up in a family culture of entrepreneurship and philanthropy, she co-founded Social Venture Partners Portland with other area investors in 2001 and has launched numerous non-profit and for-profit enterprises. She held various sales/marketing roles at Auctionpay through Series A and B rounds, a period of rapid growth which earned it numerous awards including a spot on Inc. Magazine 500 fastest growing companies list. Angela loves working with people to help accelerate the success of “the big idea” and is a proud Mom to two budding entrepreneurs, ages 11 and 15.
Show more
Investment focus
  • Local, Internet, Software
  • Convertible Note, Series A
  • United States
Portfolio highlights
  • Lish — Lish specializes in corporate catering, office catering, online catering delivery, and workplace food solutions. We serve companies in Seattle & Bellevue/Eastside, including Redmond and Kirkland.
  • Chronicled — Automating business rule enforcement in the life sciences industry through the blockchain-powered MediLedger Network
Alice Zhang Angel · San Francisco, California, United States
CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom
Portfolio highlights
  • Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Daniel M. Bradbury Angel · San Diego, California, United States
Daniel M. Bradbury is Director at Liquid Grids.
Show more
Investment focus
  • Life Science, Biotechnology
  • Series A
  • United States
Portfolio highlights
  • Alume Biosciences — Alume is a biotechnology company, developing nerve-targeted pharmaceutical agents for surgical and therapeutic use. The company's first product, ALM-488, is a fluorescently labeled peptide-dye conjugate that makes human nerves "glow," helping surgeons reduce injury to critical nerves during surgery. During surgery, inadvertentinjury to nerves leads to loss of function, including paralysis, numbness, and decreased quality of life. Alume intends to develop agents including ALM-488 to be used as an adjunct during surgery to help surgeons see nerves better compared to current visualization with white light alone. Alume's technology has the potential to improve the accuracy of nerve identification, decrease operative time, and lead to better outcomes for patients.
Willard Umphrey Angel
Bill is the Chairman and Co-Founder of the Pear Tree Funds, the President of Pear Tree Investment Advisors, Inc., and the Chairman of U.S. Boston Capital Corporation. He has over 40 years of experience in the finance and investment management business.Bill holds the Chartered Financial Analyst (CFA) designation and is a member of the CFAInstitute and the Boston Security Analysts Society. He obtained his JD from Harvard Law School, an LLM in taxation from Boston University School of Law, a Masters in Personnel Administration from George Washington University, and a BS with distinction from the United States Naval Academy in Annapolis, Maryland.
Show more
Investment focus
  • Analytics, Life Science, Biotechnology
  • Seed
  • United States
Portfolio highlights
  • Thrive Bioscience — Thrive Bioscience is commercializing a family of instruments and software that provide imaging, analytics, and automation to significantly improve cell culture and the analysis of live cells. Thrive’s instruments empower biologists to deliver consistent, reproducible results by leveraging microscopy, robotics, fluidics, and other fields, to captureimages and data and provide analysis, reports, guidance, documentation, and a database on the cells and on cell culture processes.
Paul Manning Angel · Charlottesville, Virginia, United States
Paul B. Manning has served as the chairman of our board of directors since December 2017 and as a member of our board of directors since December 2015. Mr. Manning is the Chairman and Chief Executive Officer of PBM Capital Group, LLC, a private equity investment firm in the business of investing in healthcare and life-science related companies,which he founded in 2010. Prior to that, Mr. Manning founded PBM Products in 1997, a producer of infant formula and baby food, which was sold to Perrigo Corporation in 2010. Mr. Manning is a director of Dova Pharmaceuticals, Inc., a publicly traded pharmaceutical company, as well as various private companies. Mr. Manning was previously on the board of directors of Perrigo Corporation, Concordia Healthcare Corp. and AveXis, Inc. Mr. Manning received a B.S. in microbiology from the University of Massachusetts.
Show more
Investment focus
  • Biotechnology, Therapeutics, Medical
  • Series A, Series B, Post-IPO Equity
  • United States
Portfolio highlights
  • Kriya Therapeutics — Kriya is a next-generation gene therapy company focused on designing and developing transformative new treatments for highly prevalent and severe chronic diseases. We target conditions where the underlying biology is well-understood, rationally designing one-time gene therapies to durably express therapeutic proteins within the appropriate humantissues. Our team has deep expertise in the field and includes former senior leadership from pioneering gene therapy companies and academic institutions. We use algorithmic tools, scalable infrastructure, and proprietary technology to optimize the efficacy and durability of our gene therapies – with a goal of transforming the treatment paradigm for some of the most serious and widespread diseases.
  • Liquidia Technologies — Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed toimprove the safety, efficacy, and performance of a wide range of therapies. Currently, Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. In addition to developing our own product candidates, Liquidia collaborates with leading pharmaceutical companies to apply our PRINT technology across a wide range of therapeutic areas, molecule types, and routes of administration.
  • The Paul and Diane Manning Institute of Biotechnology — The Paul and Diane Manning Institute of Biotechnology engages in the medical research that leads to new medical treatments, including cellular therapy, gene therapy, nanotechnology and drug delivery.
Lu Yoh-Chie Angel
Lu, the founder of Biosensors International Group Ltd, was its chairman and CEO from its inception to 2008. He retained his leadership position as chairman of the Group since January 2008. Today BIG is one of the leading medical device companies with a market cap in excess of $1.6B.
Show more
Investment focus
  • Medical, Health Care, Artificial Intelligence
  • Seed, Series A
  • United States
Portfolio highlights
  • Bot MD — Bot MD Care is an A.I. clinical chat assistant. Our A.I. integrates hospital information to provide instant answers to doctor queries and helps automates patient monitoring.
  • BioTrillion — We so often think of Healthcare as an industry, that we tend to forget about Healthcare as a purpose. Globally and annually, trillions of dollars are ineffectively spent on healthcare and trillions of life data points are ineffectively connected to insights about our health. There is a better way.BioTrillion is a little startup with boldambitions to more efficatiously and scalably advance Healthcare – via Digital Biomarkers.Every human generates massive amounts of life data that will unlock novel health insights & applications. BioTrillion is developing a mobile health technology platform called BioEngine4D™ – for digitally detecting dangeous drugs, digitally detecting developing diseases, and data driven drug development – by measuring data from life, analyzing it through computational advancements in machine learning and artificial intelligence, and applying it back for life.BioTrillion, Inc. is headquartered in San Francisco, CA and is reimagining Life Sciences through the fundamental principles of many sciences.Our mission is to enable consumer smart devices to empower ordinary consumers with extraordinary health insights. Advances in technology have amplified our individual capabilities in many ways, and healthcare should be no exception.Website: www.biotrillion.com Contact: contact@biotrillion.com Jobs: https://www.biotrillion.com/opportunities Application: https://biotrillion.typeform.com/to/wSvoKI
Scott Garber Angel · Baltimore, Maryland, United States
Scott Garber is the Managing Partner of Early Light Ventures. He attended The George Washington University School of Business.
Show more
Investment focus
  • Software, Information Technology, Cyber Security
  • Seed, Pre-Seed, Series A
  • United States
Portfolio highlights
  • Ethix360 — ETHIX360 provides Compliance as a Service (CaaS); a simple, affordable answer to employee ethics communication and human resources case management.
  • Ash & Erie — Men's clothes designed from scratch for shorter men 5'8" and under. Find men's casual and formal clothing from button-downs, t-shirts, sweaters, denim jeans, chinos, and more. FREE Shipping, Exchanges, and Returns.
  • Outlogic — Outlogic is a provider of location data for the retail, real estate, and financial markets. Outlogic has exemplified high standards and best practices for the collection and use of location data while still allowing companies to develop disruptive tools built on a foundation of quality data.
Wes Osbourn Angel
Wes Osbourn
Show more
Investment focus
  • Chemical, Life Science, Biotechnology
  • Pre-Seed
  • United States
Portfolio highlights
  • Capra Biosciences — We use biology to make high performance renewable chemicals affordable and sustainable. We are revolutionizing chemical production with our patented bioreactor technology.
Ali Shaaban Angel · Cairo, Al Qahirah, Egypt
Ali Shaaban has been a pioneer in the digital advertising and communications industry for more than 18 years, founding the award-winning full-fledged creative digital agency Icon Creations back in 2003 when the industry was at its infancy stage. Since then, Ali Shaaban has built strong long-term relationships and a strategic network with most ofthe leading automotive brands in Egypt and the Middle East, where he established a solid track record of delivering top-notch digital products & services that stood the test of time. Driven by passion for excellence and an always-on personalized approach to satisfying his partners, Ali Shaaban is the quintessential digital partner to have on your side in the automotive industry today.His automotive portfolio includes Alfa Romeo, Bentley, BMW, Castrol, Citroën, Ferrari, Fiat, Ford, Hyundai, JAC, Jaguar, Jeep, KIA, Land Rover, Maserati, Mazda, MINI, Mitsubishi, Nissan, Peugeot, Pirelli, Renault, Seat, Subaru, Toyota, Volkswagen and more. Aside from being a digital pioneer, Ali Shaaban is also an angel investor and serial supporter of emerging innovative startups and fresh business ideas, venturing into several sectors to contribute in making a sustainable impact on the local and regional economies. His latest investments have tapped into the Fintech sector with rising companies such as Paynas (https://Paynas.com), Oxygen (https://oxygen.us/), Dfin Holding (https://www.dfinholding.com/) , and Kiwe wallet (https://kiweapp.com/) as well as the Media and AI sector with Speakol (https://speakol.com/) , NU Digital Awards (https://nudigitalawards.com/) and Nanotronics (https://nanotronics.co/ ).Ali Shaaban believes in always taking the next step forward in his extensive career, and using his core values and commanding personality as motivation, he has paved an impressive path over the years that will certainly lead towards an even more diverse and fruitful future.
Show more
Investment focus
  • Financial Services, FinTech, Banking
  • Series A, Seed, Pre-Seed
  • Egypt, United States, Kenya
Portfolio highlights
  • ImaliPay — ImaliPay is a financial health platform offering financial products to freelancers and blue collar gig workers in partnership with gig platforms.
  • QuadriBot — QuadriBot is an engineering company specializing in the design and development of electronics and automation technology, real-time systems and the development of IT and electronic solutions around smart transportation issues. We focus on robotics and autonomous vehicles as well as any mobile platfo.
  • Nanotronics Imaging — At Nanotronics we provide customized solutions for automated optical inspection, process control, and security. Learn more about what we can do for you.
Jeff Raikes Angel · Seattle, Washington, United States
Jeff Raikes is the Co-founder of the Raikes Foundation.
Show more
Investment focus
  • Video, AgTech, Sports
  • Series A, Series C, Series D
  • United States
Portfolio highlights
  • Hudl — Hudl provides video review and performance analysis tools for sports teams and athletes at every level.
  • Epicrop Technologies — The only company using a nature-based epigenetic approach to enhance crops, accelerating development and delivering proven results.
Idris Ayodeji Bello Angel
The 'Afropreneur' (entrepreneur with an African focus), as he self-describes, Idris Ayodeji Bello is a Partner at LoftyInc Allied Partners Limited and co-founder of The Wennovation Hub, an innovation platform based in Nigeria, that has successfully accelerated the launch of several technology start-ups in social impact sectors. He isalso a Founding Partner at Loftyinc Capital Management, owners of the Afropreneurs Fund (I&II)The 'Afropreneur' (entrepreneur with an African focus), as he self-describes, Idris Bello is a Partner at LoftyInc Allied Partners Limited and co-founder of The Wennovation Hub, an innovation platform based in Nigeria, that has successfully accelerated the launch of several technology start-ups in social impact sectors. He is also a Founding Partner at Loftyinc Capital Management, owners of the Afropreneurs Fund (I&II)A first class honors graduate of Computer Engineering from Obafemi Awolowo University, Nigeria, he has an M.Sc in Computer Science & Data Mining from the University of Houston; an MBA in Entrepreneurship & Strategy from Rice University in Houston and an M.Sc in Global Health Science from the University of Oxford, where he was a 2011 recipient of The Lord Weidenfeld Scholarship for demonstrating remarkable potential as a future leader from an emerging economy.Idris spent the greater part of a decade working at Chevron Corporation and ExxonMobil USA, where he led several large upstream technology projects across the USA and Sub-Saharan Africa. Idris has also worked with the Clinton Foundation Health Access Initiative where he played a major role in the deployment and evaluation of Swaziland’s first mobile health patient appointment reminder system as part of the country’s National AIDS Program. Listed among CNN’s Top Ten African Technology Voices, he is a Singularity University Impact Fellow, Harambe Entrepreneur Alliance Associate, Clinton Global Initiative University Fellow, MIT Global Start-up Fellow, SAP Ashoka Global Changemakers Award Winner, Dell Technology Award Winner, StartingBloc Innovation Fellow and a Nigeria Leadership Initiative Future Leader.As a leader, Idris has mentored and catalyzed scores of contributors across the growing African landscape and is an angel investor and advisor to several African startups including Andela, Flutterwave, RelianceHMO, among others. He continues to devote his efforts to the development of innovation-driven, technology-enabled social enterprises that empower the underserved and develop transformative ideas to change lives on the African continent.He spends most of his time between Lagos, Cairo, or airport lounges.
Show more
Investment focus
  • Software, FinTech, Mobile Apps
  • Angel, Seed, Pre-Seed
  • Nigeria, United States, Egypt
Portfolio highlights
  • Jem — We give employers the ability to send company-wide communications, deliver payslips, manage leave & give employees access to their earnings, via WhatsApp.
  • SimpliFi — SimpliFi is on a mission to democratize payments by building the leading Cards as a Service (CaaS) platform for MENA and Pakistan.
  • ORDA — Process orders, accept payments, connect to logistic providers, engage with your customers + more. We equip you with everything you need to grow your business.
Haig Farris Angel
Haig Farris is one of Canada's best-known venture capitalists and experts in high-technology start-ups and turn-arounds, with a varied 30+ year history of involvement, commitment, and management. He has a law degree from the University of Pennsylvania. He is co-founder and former Executive Chair of the Board of Directors of D-Wave, and he isthe President of Fractal Capital, a private venture capital company financing high technology start-ups and resource service technology companies.Previously, Dr. Farris was a co-founder and partner of the Ventures West Management group of venture capital funds (1972-1990). In 2001, he received the British Columbia Technologies Industry Association's (BCTIA) Bill Thompson Award.He was awarded an Honorary Doctor of Laws degree from UBC in 1997 and named A Pioneer of Innovation by the Vancouver Board of Trade in 2001.
Show more
Investment focus
  • Biotechnology, Genetics, Life Science
  • Seed, Pre-Seed
  • Canada, United States
Portfolio highlights
  • Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
  • Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
Douglas Hansen Angel · New York, New York, United States
Douglas B. Hansen is a co-founder of Redwood and served as Redwood’s President from 1994 through 2008. Mr. Hansen retired from his position as President of Redwood at the end of 2008. Mr. Hansen has been a director of Redwood since 1994. Mr. Hansen serves on the Board of Directors of Four Corners Property Trust, Inc., a publicly traded real estateinvestment trust. Mr. Hansen also serves on the board of River of Knowledge, a not-for-profit institution. Mr. Hansen holds a B.A. in Economics from Harvard College and an M.B.A. from Harvard Business School.
Show more
Investment focus
  • Analytics, Life Science, Biotechnology
  • Seed
  • United States
Portfolio highlights
  • Thrive Bioscience — Thrive Bioscience is commercializing a family of instruments and software that provide imaging, analytics, and automation to significantly improve cell culture and the analysis of live cells. Thrive’s instruments empower biologists to deliver consistent, reproducible results by leveraging microscopy, robotics, fluidics, and other fields, to captureimages and data and provide analysis, reports, guidance, documentation, and a database on the cells and on cell culture processes.
Norman Sorensen Angel · Des Moines, Iowa, United States
Norman Sorensen who is a Class II director, joined the Board of Directors in March 2015. He is a member of the Company’s Finance, Risk Management and Audit Committee. Mr. Sorensen formerly served as chairman of the International Insurance Society, Inc., a professional organization for the insurance industry, from January 2010 until June 2013. Mr.Sorensen has served as a director of the International Insurance Society, Inc. since January 2005. Previously, from November 2011 until December 2012, he was chairman of the International Advisory Council of Principal Financial Group, Inc., a global financial investment management company. He was chairman of Principal International, Inc., serving from June 2011 to October 2012, and president and CEO of International Asset Management and Accumulation of Principal International, Inc., serving from January 2001 to June 2011. Mr. Sorensen has served as a director of Encore Capital Group, Inc., a consumer banking company, since November 2011. Mr. Sorensen also served as a director of Sara Lee Corporation, an American consumer-goods company, from January 2007 to November 2011. He has served as executive vice president of both Principal Financial Group Inc. and Principal Life Insurance Company, a life insurance company, since January 2007, and held a number of other senior management positions since 1998. Mr. Sorensen also served as chairman of the U.S. Coalition of Service Industries, a leading forum for the services sector, from January 2003 to March 2005. Mr. Sorensen served as a senior executive of American International Group, Inc., an insurance services company, from September 1989 to December 1998. He also formerly served as chairman and director of DE Master Blenders, from December 2011 until September 2013.
Show more
Investment focus
  • SaaS, FinTech, Analytics
  • Seed
  • United States
Portfolio highlights
  • Solidus Labs — The first automated, comprehensive and testable market surveillance and risk monitoring hub tailored for digital assets
  • Thrive Bioscience — Thrive Bioscience is commercializing a family of instruments and software that provide imaging, analytics, and automation to significantly improve cell culture and the analysis of live cells. Thrive’s instruments empower biologists to deliver consistent, reproducible results by leveraging microscopy, robotics, fluidics, and other fields, to captureimages and data and provide analysis, reports, guidance, documentation, and a database on the cells and on cell culture processes.
Leonardo DiCaprio Angel · Los Angeles, California, United States
Leonardo DiCaprio is an American actor and film producer. He has been nominated for three Academy Awards and nine Golden Globe Awards. He won the Golden Globe Award for Best Actor for his performance in The Aviator (2004), and has been nominated by the Screen Actors Guild, Satellite Awards, and the British Academy of Film and Television Arts. Acommitted environmentalist, DiCaprio has received praise from environmental groups for his activism. At the 2007 Oscar ceremony, DiCaprio and former Vice President Al Gore announced that the Academy Awards had incorporated environmentally intelligent practices throughout the planning and production processes, and on July 7, 2007, DiCaprio presented at the American leg of Live Earth.
Show more
Investment focus
  • Food and Beverage, Food Processing, Health Care
  • Series A, Funding Round, Seed
  • United States, Israel, Switzerland
Portfolio highlights
  • Polestar — Wir stellen Performance-Elektroautos her. Unser Ziel: eine bessere Zukunft durch Innovationen.
  • ID Genève — We make watches that reflect the values and principles of people who are committed to fight climate change and who wish to have a positive social and environmental impact. The materials used are circular and have a lower carbon footprint than the industry average.
  • NUVIEW — Explore NUVIEW's LiDAR satellite technology, revolutionizing Earth observation with annual global mapping, unrivaled coverage, and cutting-edge data.
Ling Wong Angel · Seattle, Washington, United States
Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. She also serves as Senior Advisor to Lightspeed Venture Partners. Highbury Group was founded on the principle to be a true partner and champion to entrepreneurs, using science and technology to build companies that fundamentally transform the world for thebetterment of humanity today, and in the future.Dr. Wong draws from her unique background and experience as a scientist, entrepreneur, and investor to support and bring to market companies that exist at the intersection between health and technology. “I love to partner with mission-oriented founders working on transformational ideas that can have a positive, lasting impact on society – and do so by leveraging technology and science in a financially sustainable manner,” said Dr. Wong.Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio and created a $200M early stage program to support early stage entrepreneurs in more than 60 countries.As a health and technology investor, Dr. Wong has been involved in some of the market’s most significant investments and exits. She has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC).Dr. Wong holds a PhD from Harvard in Engineering Sciences, a BSc in Chemical Engineering and BSc in Biology from MIT. During her time at Harvard, she created the world’s first inhaled TB vaccine. Her scientific training has shaped how she assesses financial opportunities, both to create value and to benefit human health. Dr. Wong has always been passionate about seeking entrepreneurs and partners that are looking to disrupt the status quo in science and technology for the betterment of society.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Colombia
Portfolio highlights
  • Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
  • Devoted Health — Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes.
  • Shape Therapeutics — Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of thesetechnologies throughout the industry to develop effective treatments for as many patients as possible.
Chloe Sladden Angel · San Francisco, California, United States
Chloe Sladden - Founding Partner @ #Angels
Show more
Investment focus
  • Software, Health Care, Mobile Apps
  • Seed, Series A, Convertible Note
  • United States
Portfolio highlights
  • Digits — Ready in seconds. No setup required.
  • Threads — Founded in 2017, Threads is a San Francisco-based company designed to help teams inform, discuss, and make decisions at scale. For leaders at every level of a company, Threads is a platform for work that best delivers on decision making by tapping into the collective wisdom of an entire team, providing everyone with a voice to assure betterbusiness outcomes. Join the future of work and learn more at threads.com or follow us on Twitter @threads.
  • Clubhouse — Clubhouse is an internet company.
Jude Gomila Angel · San Francisco, California, United States
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Pre-Seed, Angel
  • United States, United Kingdom, Canada
Portfolio highlights
  • Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
  • HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Investors by industry
Investors by country
Angel Investors in United States by industry